You have 9 free searches left this month | for more free features.

ITP

Showing 1 - 25 of 444

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Activity and Safety of Fostamatinib in Consecutive Adult ITP

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • +2 more
  • (no location specified)
Jan 12, 2023

Primary Immune Thrombocytopenia (ITP) Trial (Ianalumab)

Not yet recruiting
  • Primary Immune Thrombocytopenia (ITP)
  • Ianalumab
  • (no location specified)
Jun 5, 2023

Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP

Not yet recruiting
  • Thrombopoietin Receptor Agonist
    • (no location specified)
    May 4, 2023

    Immune Markers in Pediatric ITP

    Not yet recruiting
    • ITP - Immune Thrombocytopenia
    • complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-γ.
    • (no location specified)
    Oct 17, 2023

    Immune Thrombocytopenia Trial (peripheral blood and bone marrow withdrawal)

    Not yet recruiting
    • Immune Thrombocytopenia
    • peripheral blood and bone marrow withdrawal
    • (no location specified)
    Jan 12, 2023

    Course of COVID-19 in Prior, Ongoing or de Novo ITP. Evaluation

    Recruiting
    • Immune Thrombocytopenia
    • +3 more
      • Brescia, Italy
      • +7 more
      Aug 24, 2022

      ITP - Immune Thrombocytopenia Trial (hetrombopag 5mg po qd, High-dose Dexamethasone)

      Not yet recruiting
      • ITP - Immune Thrombocytopenia
      • hetrombopag 5mg po qd
      • High-dose Dexamethasone
      • (no location specified)
      Jul 5, 2023

      Idiopathic Thrombocytopenic Purpura, Thrombocytopenia, Thrombocytopenic Purpura Trial (Romiplostim)

      Completed
      • Idiopathic Thrombocytopenic Purpura
      • +2 more
      • Romiplostim
      • (no location specified)
      Nov 10, 2022

      Primary Immune Thrombocytopenia (ITP) Trial in Singapore (Ianalumab, Placebo, Corticosteroids)

      Recruiting
      • Primary Immune Thrombocytopenia (ITP)
      • Ianalumab
      • +2 more
      • Singapore, Singapore
        Novartis Investigative Site
      Jan 17, 2023

      Primary Immune Thrombocytopenia (ITP) Trial in Tianjin (TPO-RAs, TPO-RAs combining anti-CD 20 mAb)

      Not yet recruiting
      • Primary Immune Thrombocytopenia (ITP)
      • TPO-RAs
      • TPO-RAs combining anti-CD 20 monoclonal antibody
      • Tianjin, China
        Institute of Hematology and Blood Diseases Hospital, Chinese Aca
      Feb 7, 2023

      Some Cytokines Expression in ITP Primary Immune Thrombocytopenic

      Recruiting
      • Primary Immune Thrombocytopenia
      • Plasma RNA isolation, qPCR analysis of micro RNA
      • +2 more
      • Sohag, Egypt
        Sohag University
      May 7, 2022

      Primary Immune Thrombocytopenia (ITP) Trial in Switzerland (Eltrombopag (Revolade®), standard therapy (without eltrombopag):

      Recruiting
      • Primary Immune Thrombocytopenia (ITP)
      • Eltrombopag (Revolade®)
      • standard therapy (without eltrombopag): HD-DXM
      • Aarau, Switzerland
      • +5 more
      Sep 5, 2022

      Lupus Erythematosus, Systemic, Purpura, Thrombocytopenic, Idiopathic, Glucocorticoids Trial in Fuzhou (rapid GCs taper)

      Enrolling by invitation
      • Lupus Erythematosus, Systemic
      • +3 more
      • rapid GCs taper
      • Fuzhou, Fujian, China
        Fujian Medical University Union Hospital
      Aug 16, 2022

      Immune Thrombocytopenia Trial in Jena

      Recruiting
      • Immune Thrombocytopenia
        • Jena, Germany
          University Hospital Jena
        Mar 29, 2022

        Anesthesia, Local Trial in Roskilde (Ropivacaine injection)

        Recruiting
        • Anesthesia, Local
        • Ropivacaine injection
        • Roskilde, Zealand Region, Denmark
          Department of Anaesthesiology and Intensive Care Medicine, Zeala
        Feb 28, 2023

        Immune Thrombocytopenia, Bruton Tyrosine Kinase Trial in Beijing (Zanubrutinib)

        Recruiting
        • Immune Thrombocytopenia
        • Bruton Tyrosine Kinase
        • Beijing, Beijing, China
          Peking University Insititute of Hematology, Peking University Pe
        Mar 6, 2022

        Pediatric Primary Immune Thrombocytopenia (ITP)

        Recruiting
        • Primary Immune Thrombocytopenia
        • data collection
        • Tianjin, China
          Chinese Academy of Medical Science and Blood Disease Hospital
        Oct 31, 2023

        ITP Trial in Suzhou (autologous anti-BCMA chimeric antigen receptor T cells)

        Recruiting
        • ITP
        • autologous anti-BCMA chimeric antigen receptor T cells
        • Suzhou, Jiangsu, China
          The First Affiliated Hospital of Soochow University
        Mar 31, 2022

        Gut Microbiota in ITP

        Recruiting
        • ITP
          • Beijing, Beijing, China
            Peking University Insititute of Hematology, Peking University Pe
          Jan 11, 2022

          Fostamatinib in Patients With ITP. FOSTASUR Study

          Completed
          • Primary Immune Thrombocytopenia
          • Cadiz, Cádiz, Spain
          • +13 more
          Oct 3, 2023

          Multiple Sclerosis Trial in Los Angeles (Blood draw for future biomarker analysis)

          Completed
          • Multiple Sclerosis
          • Blood draw for future biomarker analysis
          • Los Angeles, California
            Investigational Site Number 8400001
          Mar 15, 2022

          Immune Thrombocytopenia, Pregnancy Related Trial (intravenous immunoglobulin plus low dose recombinant human thrombopoietin

          Not yet recruiting
          • Immune Thrombocytopenia
          • Pregnancy Related
          • intravenous immunoglobulin plus low dose recombinant human thrombopoietin (rhTPO)
          • intravenous immunoglobulin
          • (no location specified)
          Dec 1, 2022

          Evaluate Safety and Effectiveness of Hetrombopag in ITP or AA

          Not yet recruiting
          • Primary Immune Thrombocytopenia
          • Aplastic Anemia
          • Wuhan, Hubei, China
            Union Hospital, Tongji Medical College, Huazhong University of S
          Apr 11, 2022

          Immune Thrombocytopenia (ITP) Trial (Neofordex®, Intravenous immunoglobulins)

          Not yet recruiting
          • Immune Thrombocytopenia (ITP)
          • (no location specified)
          Nov 22, 2021

          Primary Immune Thrombocytopenia Trial (2.5mg/d Hetrombopag)

          Not yet recruiting
          • Primary Immune Thrombocytopenia
          • 2.5mg/d Hetrombopag
          • (no location specified)
          Mar 28, 2022